Finanzen von 2Seventy Bio Inc (TSVT)TSVT2Seventy Bio Inc

Evaluating the bottom line, 2Seventy Bio Inc maintains a gross margin of 77.54%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -10.74%, while the net margin is 2.10%. These profitability ratios, combined with a Return on Equity (ROE) of -1.94%, provide a clear picture of how effectively TSVT converts its operational activities into shareholder value.

In the context of the broader market, TSVT competes directly with industry leaders such as LFCR and ALMS. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, TSVT's gross margin of 77.54% stands against LFCR's 35.34% and ALMS's 100.00%. Such benchmarking helps identify whether 2Seventy Bio Inc is trading at a premium or discount relative to its financial performance.